A treatment paradigm for femoracetabular impingement (FAI)
Ended Project Grant Awarded Last action
- Award ID
- R44AR077467
- Recipient
-
Cytex Therapeutics Inc. UEI G9RMDCWJYGL3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,377,884
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Funding
-
- $2,528,458.00 Federal
- $849,426.00 Non-federal
- Place of performance
- Durham, NC 27704, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $849,426 | $0 | |
| Amendment | $849,426 | $849,426 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $829,606 | $0 |
Quick answers
Who received award R44AR077467?
R44AR077467 was awarded to Cytex Therapeutics Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on June 1, 2020.
How much is award R44AR077467 worth?
$3,377,884 has been obligated on R44AR077467: $2,528,458 in federal funding and $849,426 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award